Xvivo Perfusion AB (publ) (XVIPF)
USD 33.45
(0.0%)
USD 33.45
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 416.91 Million SEK | 40.4% |
| 2022 | 296.95 Million SEK | 57.72% |
| 2021 | 188.27 Million SEK | 41.59% |
| 2020 | 132.97 Million SEK | -18.33% |
| 2019 | 162.81 Million SEK | 19.76% |
| 2018 | 135.95 Million SEK | 19.89% |
| 2017 | 113.39 Million SEK | 10.92% |
| 2016 | 102.23 Million SEK | 20.33% |
| 2015 | 84.96 Million SEK | 32.65% |
| 2014 | 64.04 Million SEK | 18.3% |
| 2013 | 54.13 Million SEK | 374.39% |
| 2012 | 11.41 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 158.24 Million SEK | 17.13% |
| 2024 Q3 | 147.93 Million SEK | -6.52% |
| 2024 Q1 | 135.1 Million SEK | 53.57% |
| 2023 FY | 416.91 Million SEK | 40.4% |
| 2023 Q2 | 115.46 Million SEK | 10.16% |
| 2023 Q4 | 87.97 Million SEK | -18.23% |
| 2023 Q3 | 107.59 Million SEK | -6.81% |
| 2023 Q1 | 104.81 Million SEK | 10.5% |
| 2022 FY | 296.95 Million SEK | 57.72% |
| 2022 Q3 | 69.37 Million SEK | 2.76% |
| 2022 Q2 | 67.5 Million SEK | 3.5% |
| 2022 Q4 | 94.85 Million SEK | 36.74% |
| 2022 Q1 | 65.22 Million SEK | 3.34% |
| 2021 Q1 | 42.68 Million SEK | 3.2% |
| 2021 Q3 | 37.93 Million SEK | -14.84% |
| 2021 FY | 188.27 Million SEK | 41.59% |
| 2021 Q4 | 63.11 Million SEK | 66.38% |
| 2021 Q2 | 44.54 Million SEK | 4.37% |
| 2020 Q2 | 23.1 Million SEK | -34.71% |
| 2020 FY | 132.97 Million SEK | -18.33% |
| 2020 Q1 | 35.38 Million SEK | -22.59% |
| 2020 Q3 | 33.13 Million SEK | 43.42% |
| 2020 Q4 | 41.35 Million SEK | 24.82% |
| 2019 Q1 | 36.91 Million SEK | -11.63% |
| 2019 FY | 162.81 Million SEK | 19.76% |
| 2019 Q4 | 45.7 Million SEK | 18.59% |
| 2019 Q3 | 38.54 Million SEK | -7.46% |
| 2019 Q2 | 41.64 Million SEK | 12.82% |
| 2018 Q1 | 30.11 Million SEK | -5.42% |
| 2018 FY | 135.95 Million SEK | 19.89% |
| 2018 Q4 | 41.77 Million SEK | 34.59% |
| 2018 Q3 | 31.03 Million SEK | -6.03% |
| 2018 Q2 | 33.02 Million SEK | 9.69% |
| 2017 Q1 | 27.08 Million SEK | -6.23% |
| 2017 FY | 113.39 Million SEK | 10.92% |
| 2017 Q4 | 31.83 Million SEK | 26.04% |
| 2017 Q3 | 25.25 Million SEK | -13.53% |
| 2017 Q2 | 29.21 Million SEK | 7.83% |
| 2016 Q1 | 24.25 Million SEK | -1.51% |
| 2016 FY | 102.23 Million SEK | 20.33% |
| 2016 Q4 | 28.88 Million SEK | 19.19% |
| 2016 Q3 | 24.23 Million SEK | -2.51% |
| 2016 Q2 | 24.85 Million SEK | 2.5% |
| 2015 Q1 | 19.51 Million SEK | -0.46% |
| 2015 FY | 84.96 Million SEK | 32.65% |
| 2015 Q4 | 24.62 Million SEK | 28.99% |
| 2015 Q3 | 19.09 Million SEK | -12.15% |
| 2015 Q2 | 21.73 Million SEK | 11.35% |
| 2014 FY | 64.04 Million SEK | 18.3% |
| 2014 Q1 | 13.87 Million SEK | -8.91% |
| 2014 Q4 | 19.6 Million SEK | 22.9% |
| 2014 Q3 | 15.95 Million SEK | 9.18% |
| 2014 Q2 | 14.61 Million SEK | 5.3% |
| 2013 Q2 | 12.45 Million SEK | -4.81% |
| 2013 Q1 | 13.07 Million SEK | 14.61% |
| 2013 FY | 54.13 Million SEK | 374.39% |
| 2013 Q4 | 15.23 Million SEK | 13.89% |
| 2013 Q3 | 13.37 Million SEK | 7.43% |
| 2012 FY | 11.41 Million SEK | 0.0% |
| 2012 Q4 | 11.41 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Avitar, Inc. | 836.7 Thousand USD | -49728.135% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 41691400.0% |
| Urologix, Inc. | 6.09 Million USD | -6742.491% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -38007.412% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 14.14% |
| Össur hf. | 485.57 Million USD | 14.14% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -58336.436% |
| VMS Rehab Systems, Inc. | -10.44 USD | 3993419640.23% |
| QHSLab, Inc. | 793.6 Thousand USD | -52433.937% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| BrainsWay Ltd. | 23.09 Million USD | -1705.522% |
| BioElectronics Corporation | 466.38 Thousand USD | -89291.88% |
| Hamilton Thorne Ltd. | 35.08 Million USD | -1088.348% |
| Theraclion SA | -1.08 Million USD | 38689.299% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -353.46 Thousand USD | 118050.292% |
| Stratec SE | 71.58 Million USD | -482.373% |
| AVITA Medical, Inc. | 41.68 Million USD | -900.094% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 3231983.721% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 213550.167% |
| Wellstar International, Inc. | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -2389.891% |
| Escalon Medical Corp. | 5.14 Million USD | -8001.388% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -1157991.667% |
| Aurora Spine Corporation | 8.21 Million USD | -4977.313% |
| NewCardio, Inc. | 105.1 Thousand USD | -396570.885% |
| Vivos Inc. | -6036.00 USD | 6907207.356% |
| MicroPort Scientific Corporation | 532.09 Million USD | 21.647% |
| Kelyniam Global, Inc. | 2.03 Million USD | -20376.278% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 55193.368% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -736573.499% |
| Nanomix Corporation | -69.45 Thousand USD | 600337.554% |
| IR-Med Inc. | -17 Thousand USD | 2452529.412% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -70857.876% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -39776.71% |
| Lombard Medical, Inc. | 955 Thousand USD | -43555.812% |
| ALR Technologies Inc. | 4945.00 USD | -8430901.011% |
| Vycor Medical, Inc. | 1.31 Million USD | -31588.651% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -201874.14% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -2802.687% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -155129.766% |
| United American Healthcare Corporation | -8000.00 USD | 5211512.5% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 335.48 Thousand USD | -124172.467% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -23606.045% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 131746.621% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 89.34% |
| NIOX Group Plc | 28.13 Million USD | -1381.92% |
| Fuse Medical, Inc. | 10.73 Million USD | -3784.1% |
| Broncus Holding Corporation | 7.22 Million USD | -5668.825% |
| Brain Scientific Inc. | 54.32 Thousand USD | -767342.246% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -52042.673% |
| Health Logic Interactive Inc. | - USD | -Infinity% |